News and Trends 5 Jan 2023
Hummingbird Bioscience and Synaffix to develop ADC program
Synaffix B.V. and Hummingbird Bioscience have entered into a licensing agreement that will enable Hummingbird Bio to develop a next generation antibody drug conjugate (ADC) program using Synaffix technology. Synaffix…